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A B S T R A C T

Purpose: Our study aimed to validate culturally adapted English and Swahili versions of the Patient
Health Questionnairee9 (PHQ-9) for use with adolescents in Kenya. Criterion validity was determined with clinician-administered diagnostic interviews using the Kiddie Schedule of Affective
Disorders and Schizophrenia.
Methods: A total of 250 adolescents comprising 148 (59.2%) females and 102 (40.8%) males aged
10e19 years (mean ¼ 14.76; standard deviation ¼ 2.78) were recruited. The PHQ-9 was administered to all respondents concurrently in English and Swahili. Adolescents were later interviewed
by clinicians using Kiddie Schedule of Affective Disorders and Schizophrenia to determine the
presence or absence of current symptoms of major depressive disorder. Sensitivity speciﬁcity,
positive predictive value (PPV) and negative predictive value (NPV), and likelihood ratios for
various cut-off scores for PHQ-9 were analyzed using receiver operating characteristic curves.
Results: The internal consistency (Cronbach’s a) for PHQ-9 was 0.862 for the English version and
0.834 for Swahili version. The area under the curve was 0.89 (95% conﬁdence interval, 0.84e0.92)
and 0.87 (95% conﬁdence interval, 0.82e0.90) for English and Swahili version, respectively, on
receiver operating characteristic analysis. A cut-off of  9 on the English-language version had a
sensitivity of 95.0%, speciﬁcity of 73.0%, PPV of 0.23, and NPV of 0.99; a cut-off of  9 on the Swahili
version yielded a sensitivity of 89.0%, speciﬁcity of 70.0%, PPV of 0.20, and NPV of 0.90.

IMPLICATIONS AND
CONTRIBUTION

This study reports the psychometric properties of a
culturally translated and
adapted version of the PHQ9 in Kenya for depression
screening in adolescents
aged 10e19 years and aged
15e19 years. The results
provide information on a
range of cut-off scores so
that clinicians, policymakers, and researchers
can use thresholds that best
ﬁt their intended
objectives.
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Discussion: Psychometric properties were comparable across both English-adapted and Swahiliadapted version of the PHQ-9, are reliable, and valid instrument to detect major depressive disorder among adolescents which can be used in resource-limited settings for early identiﬁcation of
adolescents in need of mental health support.
Ó 2022 Society for Adolescent Health and Medicine. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Background
Anxiety and depressive disorders represent more than 40% of
the burden of mental disorders for adolescents aged 10e19 years
around the world [1]. Across low-income and middle-income
countries (LMICs), a lack of country-level data on adolescent
mental health is pervasive and a main bottleneck for prioritizing
this important public health issue. For example, in Kenya, mental
disorders top the list of causes of years lived with disabilities [2],
and studies carried out locally have found the prevalence of
adolescent depression and anxiety in Kenya to be an issue of
signiﬁcant concern [3,4]. However, estimates of the burden
of mental disorders in Kenya have not used tools that have been
culturally adapted and clinically validated locally; this means
that current prevalence estimates are not cultural aspects of
mental health. This risks potential overestimation or underestimation of the burden, which hinders the ability to work toward
promoting and scaling up programs and services to support
adolescent mental health [5]. Lack of valid data and the absence
of related policy dedicated to child and adolescent mental health
are limiting factors in implementing mental health strategies for
adolescents in Kenya and many other LMICs [6,7].
Therefore, clinical validation of a depression screening tool
for adolescents was undertaken in Kenya to establish the psychometric properties of both the local English dialect and
Swahili versions. The goal was to develop data so that clinicians,
public health researchers, and policymakers could make
appropriate prevalence estimates and clinical or policy decisions to understand population level prevalence of depression. For example, validation outcomes will be useful to identify
a range of cut-offs to detect depression while minimizing false
positives, thus limiting additional burdens on health providers
and potential stigmatization of respondents, while also minimizing false negatives to assure those in need of services can
obtain them. Moreover, the simultaneous validation in English
and Swahili would allow the use of both versions of the tool and
adjustments for cut-offs based on language of completion so
that data would be comparable. This research is a part of
ongoing work led by United Nations Children’s Fund (UNICEF)
and in collaboration with key institutional and academic partners from Kenya to conduct and promote cultural adaptation
and validation of adolescent mental health assessment tools.
UNICEF’s Measurement of Mental Health among Adolescents at
the Population Level (MMAP) initiative [8] developed a protocol
for cultural adaptation and criterion validation using structured
diagnostic clinical assessments to harmonize efforts across
countries.
The conceptual framework centers around UNICEF’s impetus
promote systematic data collection of adolescent mental health
using tools that are culturally adapted for use among adolescents.
In the UNICEF State of the World Children’s report (2021) [9],
MMAP initiative was identiﬁed as a robust and methodological

approach to collecting and managing mental health data for adolescents globally.
Figure 1 provides the theoretical framework for the validation
study here, which is based on the MMAP protocol [8], which
developed an approach for feasible and sustainable data collection on adolescent mental health at population level. Our validation study provides evidence on accurate identiﬁcation of
adolescents in need of a mental health assessment by using
culturally adapted tools. The analytical approach includes
sensitivity and predictive value of these measures. Through this
approach we are generating evidence for recommendation of use
of these tools in diverse country contexts where psychiatric
morbidity is high and due to many factors including a lack of
culturally adapted and feasible tools, an impact has not been
widely assessed at country levels.
In Kenya, Swahili is a national language and is used across
different regions as the ofﬁcial communication language in
addition to English. To the best of our knowledge, there is no
study that has validated both the local English dialect and
Swahili versions of Patient Health Questionnairee9 (PHQ-9) for
use among adolescents in Kenya (but also within the larger
Swahili-speaking African countries). A previous study among
head and neck cancer patients conducted in Kenya by Omoro
et al. translated and validated a Swahili version of PHQ-9 [10],
whereas Monahan et al. and Mwangi et al. administered and
investigated the reliability and validity of the English version of
PHQ-9; the latter used Swahili version of the PHQ-9 among
adults living with HIV/AIDS [11,12].
In light of the aforementioned, we focus on reporting on (1)
the internal consistency, (2) test-retest reliability, (3) receiver
operator characteristics, and (4) discriminant validity of both
English and Swahili PHQ-9 among adolescents in Kenya aged
10e19 years.
Age-speciﬁc data on health are required under the 2030
Sustainable Development Goals agenda and the World Health
Organization and partners ‘recommended standardized age
groups when reporting on health data, especially when reporting
on multiple diseases simultaneously, burden of disease, or a not
previously recognized disease or condition. In this study, adolescents are grouped in two age groups: young adolescents aged
10e14 years and older adolescents aged 15e19 years [13].
Methods
Settings
Kenya is a lower-middle-income county, as per the World
Bank Income classiﬁcation in 2021 [14]. Located in Sub-Saharan
Africa, Kenya is home to 47.5 million people as per the 2019
population census [15], of which one in four are adolescents aged
10e19 years. Kenya is a multilingual country, with English and
Swahili, a Bantu language, as ofﬁcial languages [16]. The work
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presented in this analysis was conducted in Nairobi, the capital,
with an estimated population of 4.4 million people. The cultural
adaptation and validation activities described in this article took
place in Kariobangi and Kangemi health centers run under
County Government’s Nairobi Metropolitan Services.
Participants and recruitment
Recruitment of participants and administration of assessments took place between June and July 2021. The sampling for
the validation was designed to be “enriched” for participants
likely to have symptoms of depression for comparison with
“controls” presumed not to have the condition. The desired ratio
among the selected participants was 2:1 for likely cases of
depression versus those likely without the condition. This
approach was used to ensure a large enough sample size for
participants with depression to allow for conducting a full range
of psychometric analyses for validation against the clinical
diagnosis [17].
Recruitment was conducted using a two-stage targeted
approach (Figure A1): (1) The community case detection tool for
children and adolescents [18,19] was used by community health
workers to identify participants, participants identiﬁed by community health workers from households that had family issues,
marital conﬂicts among parents were invited as likely to have
depression and (2) pregnant and parenting adolescents subsample were identiﬁed from an ongoing study under which this
work was embedded.
Instruments
Patient health questionnairee9. The PHQ-9 is a nine-item selfreport scale consisting of the nine criteria used for diagnosis of
depression in the Diagnostic and Statistical Manual of Mental
Disorders (DSM-5) [20,21]. This scale is derived from the primary
care evaluation of mental disorders, an instrument developed to
assist primary care clinicians in making diagnoses of most
common mental disorders [22].
The nine-item PHQ-9 scale is one of the tools included in the
MMAP protocol for assessing symptoms of depression among
adolescents. The tool was developed with the purpose of
screening for and assessing the severity of depressive symptoms
in both clinical and research contexts [20]. The initial validation
research of PHQ-9 demonstrated strong reliability and criteria,
concept, and external validity, in a large primary care sample [20].
Subsequently, the psychometric properties of PHQ-9 have been
evaluated in different samples of patients, including other primary
care samples [23e26], psychiatric patients [27,28], pregnant
women [29], speciﬁc groups of medical patients [11,12,30,31], and
also in diverse multicultural populations [32e34]. In an academic
setting, validation of PHQ-9 scale was performed among university students of Korea [35], China [36], and Nigeria [37].
The PHQ-9 was translated into Swahili and adapted for English as spoken in Kenya based on the transcultural translation
and adaptation process [38], previously adapted for use with
children and adolescents [8,39] (adapted tool in Supplemental
Material Box 1 and 2).
Kiddie schedule for affective disorders and schizophrenia. The
Kiddie Schedule for Affective Disorders and Schizophrenia
(K-SADS) is a semi-structured diagnostic clinical interview for
children aged 6e18 years [40]. Clinicians receive formal training
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to administer the K-SADS. The current version of the K-SADS
provides criteria-based algorithms to assess presence of current
mental health disorders consistent with DSM-5 criteria [40,41].
For this study, we used the depression section of the screening
module and the depression supplementary module. K-SADS
diagnosis of major depressive episodes was used as a criterion
standard to determine validity of psychometrics of the Kenyan
English and Swahili versions of the PHQ-9.
Participants ﬁrst completed the adapted PHQ-9 alongside the
other mental health modules in the MMAP tool [8]. Then, within
the next 48 hours, trained clinicians assessed participants using
the K-SADS. Clinicians administering the K-SADS were blind
to the results for the participant’s PHQ-9 score.

Training
Community Health Volunteers were trained to administer
the MMAP tool, including the PHQ-9. Community Health Assistants were trained to provide supervision. Twenty clinicians
(clinical ofﬁcers, psychiatric nurses, psychologists, and psychiatrists) were trained to administer the K-SADS tool. Training
included pair assessments and calculation of inter-rater reliability to ensure participants were being scored by the clinicians consistently and comparably. Of these, 12 clinicians who
met the inter-rater reliability (IRR) requirements (IRR of 0.7 and
more) were invited to conduct the diagnostic assessment using
this tool. Data collection was conducted in English and Swahili,
and all of our enumerators and clinicians and the respondents
were ﬂuent in both languages.
Statistical analysis
Sample size. The desired sample size was determined with the
goal of obtaining a sample sufﬁcient to estimate the receiver
operating characteristic (ROC) curve and area under the curve
(AUC) for the tool to be translated, adapted, and validated.
Although a priori sample size determinations for AUC are highly
susceptible to assumptions about the performance of the test
[42], a sample size of 100 is generally sufﬁcient to make a qualitative assessment of the utility of a test [43]. Over-recruitment of
the target conditions is critical. That is, we require strategies to
identify youth most likely to have the mental health concerns of
interest. Given this backdrop, a sample of 150þ was considered
for recruitment to test positive for depression/anxiety using
community case detection tool (for caseness) and a sample of 100
participants negative for depressive or anxiety disorders. We
added a sample of 50 pregnant adolescents to capture local
contextual realities.

Data analysis
Item means, standard deviations (SDs), frequencies, and
percentages were calculated for the sociodemographic variables.
Independent samples t-tests were carried out to compare the
mean PHQ-9 scores in the groups of depressed and not depressed
participants as per the K-SADS.
Reliability. To investigate the reproducibility and consistency of
PHQ-9, reliability coefﬁcients as measured by Cronbach’s alpha
were calculated.
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Figure 1. Theoretical framework of PHQ-9 validation.

Criterion validity. The following measures of criterion validity
were used in the analysis: sensitivity, speciﬁcity sensitivity, ROC
curve, and AUC.
Sensitivity and speciﬁcity. For each PHQ-9 cut-off point, sensitivity (or true positive rate) and speciﬁcity (or true negative
rates) were calculated. In our case, sensitivity is deﬁned by the
proportion of individuals with current depressive episodes as per
K-SADS criteria who were correctly identiﬁed by PHQ-9, whereas
speciﬁcity is deﬁned as the proportion of individuals without
depression as per standard-SADS who were correctly identiﬁed
as such by PHQ-9. Positive likelihood ratio (þLR) and negative
likelihood ratio (LR) and 95% conﬁdence intervals (CIs) for each
of these parameters were reported. We deﬁned þLR as the

probability of an individual without the condition having a
positive test, whereas LR was deﬁned as the probability of an
individual without the condition having a negative test. Sensitivity and speciﬁcity were plotted on a curve, creating the ROC
curve (Figure 2). The ROC curve is a plot of the sensitivity versus
[1-speciﬁcity] overall possible threshold values of the test being
validated.
The AUC, which is the area under the ROC curve, was calculated. AUC is a key psychometric that gives the probability that
the instrument will yield a higher score for a randomly chosen
individual with the target condition than for a randomly chosen
individual without the condition [44].
Positive predictive value (þPPV; proportion of true positives
on the K-SADS among all positives identiﬁed by the PHQ-9) and
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Figure 2. Area under the curve for PHQ-9 by K-SADS depression in English and Swahili and age.

negative predictive value (NPV; proportion of true negatives on
the K-SADS among all those who scored negative by PHQ-9) were
calculated.
Diagnostic odds ratio (OR) (the odds of a positive test in those
with disease relative to the odds of a positive test in those
without disease [45]) was computed in terms of sensitivity and
speciﬁcity and in terms of positive and negative likelihood ratios
(DOR ¼ LRþ/LR-). Thus, this single measure includes information
about both sensitivity and speciﬁcity and tends to be reasonably
constant despite diagnostic threshold.
Youden’s index can be used as one type of criterion for
choosing the “optimal” threshold value for the PHQ-9 test, the
threshold value for which the value of [sensitivity þ
speciﬁcity 1] is maximized. PHQ-9’s accuracy (proportion of
results, both positive and negative, correctly identiﬁed by the
PHQ-9 at different cut-offs) was estimated by the area under
the ROC curve.
Discriminant ability of the adapted PHQ-9 items for adolescents with and without diagnosis as per K-SADS was also
analyzed by calculating means and SDs and compared using

t-tests, conducted separately for the overall sample and older
adolescents aged 15e19 years with Bonferroni correction for
multitesting.
Results were analyzed separately for English and Swahili
responses for the overall sample in addition to respondents aged
15e19 years. All analyses were performed using Stata version
14.0 software and R-Version 4.1.2.
Ethical approval
The study was approved by the Kenyatta National Hospital/
University of Nairobi Ethical Review Committee (approval no.
P694/09/2018). An approval was received from Nairobi County
Health no. CMO/NRB/OPR/VOL1/2019/04 and a permit from the
Kenyan National Commission for Science, Technology, and
Innovation (NACOSTI/P/19/77,705/28,063) was subsequently
obtained. Participants who were at a high risk of depressive
disorder, deﬁned as those who were experiencing high distress,
or those who were suicidal (positive score on PHQ-9) and/or
assessed by the clinician to be warranting further assessment or
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Figure 3. Visualization for estimating true depression prevalence based on PHQ-9 obtained prevalence for the Kenyan English and Swahili versions using the psychometric properties obtained in this study.

treatment were referred to the Kenyatta National Hospital’s
Department of Mental Health where three clinicians were
requested to review their case and offer management. The
community health workers embedded under the MMAP study
made further family-based and community-based follow-ups as
needed.

Results
A total of 250 adolescents comprising 148 (59.2%) females and
102 (40.8%) males, aged 10e19 years with mean of 14.76, SD ¼
2.78, of these the percentage of those aged 10e14 years was
45.2%, whereas those aged 15e19 years was 54.8%.
Among the 15e19-year-olds, 90 (65.7%) were girls and 47
(34.3%) were boys. All participants were ﬂuent in English and
Swahili. Regarding K-SADS results for clinical diagnoses, 19 adolescents fulﬁlled the criteria for K-SADS DSM-5 depression, with
ﬁve adolescents among the 10e14 year-old group and 14 adolescents in the 15e19-year-old group (Table 1).

Psychometric analysis
The AUC for the English language version of the scale for
sample was 0.886 (95% CI, 0.840e0.923). The AUC for the Swahili
version of the scale was 0.865 (95% CI, 0.817e0.905; Figure 2).
. The AUC for the English language version of the scale for
adolescents aged 15e19 years was 0.905 (95% CI, 0.843e0.949)
and 0.870 (95% CI, 0.801e0.921) for the Swahili version.
The PHQ-9 had high internal consistency (Cronbach alpha
[a] ¼ 0.834 for the English version and a 0.862 Swahili version
and a ¼ 0.835 for 15e19-year-olds for both English and Swahili
version). The test-retest reliability for English version was
r ¼ 0.530, P < .001 and Swahili was r ¼ 0.773, P < .001.
Results in English and Swahili did not vary signiﬁcantly.
Table 2 presents the psychometric properties of the adapted
PHQ-9 in English and Swahili compared with K-SADS depression.
The appropriate cut-off point was 9 for both the English and
Swahili versions. At this point, the sensitivity was 95.0% and the
speciﬁcity was 73.0%. The PPV and NPV were 23.0% and 99.0%,
respectively. The positive and negative likelihood ratios at this
point were 3.53 and 0.77, respectively. The diagnostic OR was
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Table 1
Demographics of participants
Variable

Category

10e14 years
(n ¼ 114)

15e19 Years
(n ¼ 136)

Total sample
(n ¼ 250)

Age
Gender

Mean (SD)
Male
Female
Primary
Secondary
Higher
Negative (no condition)
Depression CCDT positive
No Depression
Depression diagnosis

12.07
58
55
110
3
0
58
55
108
5

16.97
90
47
31
97
9
49
88
123
14

14.76
102
148
141
100
9
107
143
231
19

Highest level of education attained

Community Case Detection Tool (CCDT) for recruitment
Kiddie Schedule of Affective Disorders and Schizophrenia (K-SADS)

49.1 and the accuracy was 74.8% for the English version. The
sensitivity was 89.0% for the Swahili version and the speciﬁcity
was 70.0%. The PPV and NPV were 20.0% and 99.0%, respectively.
The positive and negative likelihood ratios at this point were
2.95 and 0.15, respectively. The diagnostic OR was 19.6 and the
accuracy was 71.2%.
The appropriate cut-off point for the adolescents aged 15e
19 years was 10 for English version and 9 for Swahili version.
At this point, the sensitivity was 93.0% for both English and
Swahili versions and speciﬁcity was 74.0% for English version
and 67.0% for Swahili version. The PPV and NPV were 29.0%
and 99.0%, respectively, for English version and 25.0% and 99.0%,
respectively, for Swahili version. The accuracy was 75.9% for the
English version and 70.1% for Swahili version. The diagnostic OR
was 37.0 for English and 27.0 for Swahili version.
Item analyses
Item means were calculated for adolescents diagnosed with
depression versus adolescents who did not receive any diagnosis.
The discriminant ability of the items is presented in Table 3. Most
of the PHQ-9 items in both Swahili performed well; this is made
evident by signiﬁcant differences between respondents with and
without diagnosis in all the items. However, some items performed poorly in discriminating between those with and
without K-SADS depression diagnoses. When using the entire
sample, the items performing poorly included PHQ Item #1
(Little pleasure/interest), Item #3 (Sleep) in English, and Item #7
(Shida ya kuzingatia au kuwa makini/Trouble concentrating) in
Swahili; there were no signiﬁcant differences in these items
based on depression status. There were signiﬁcant differences
among the older adolescents in all the items except Item #1 (little
interest or pleasure) in English. However, the total score for both
language versions demonstrated a signiﬁcant difference in their
discriminant ability overall. For the total sample PHQ-9 score in
English, the mean among the adolescents with depression
(mean ¼ 15.84, SD ¼ 6.34 p < .001) was more than the mean
among the adolescents without depression (mean ¼ 6.55, SD ¼
5.05 p < .001).
The means for each of the nine PHQ items by K-SADS diagnostic status comparing depression diagnosis with no diagnosis
are presented in Figure A2. In English, item number 6, “Feeling
bad about yourself,” was the most commonly endorsed symptom
among diagnosed adolescents. Item number 2 “Feeling down/
depressed” was the most commonly endorsed symptom among
nondiagnosed participants. This was also the most commonly
endorsed item in the Swahili scale among all (diagnosed and

(1.45)
(51.3%)
(48.7%)
(97.3%)
(2.7%)
(0%)
(51.3%)
(48.7%)
(95.6%)
(4.4%)

(1.24)
(65.7%)
(34.3%)
(22.6%)
(70.8%)
(6.6%)
(35.8%)
(64.2%)
(89.8%)
(10.2%)

(2.78)
(40.8%)
(59.2%)
(56.4%)
(40%)
(3.6%)
(42.8%)
(57.2%)
(92.4%)
(7.6%)

nondiagnosed) participants. All items had good discriminatory
ability between the groups.
Application of the validation results: adjustments for population
prevalence
The validation results can aid policymakers in improving the
accuracy of population estimates of adolescent depression. Using
cut-offs that balance sensitivity and speciﬁcity, Figure 3 presents
visualization for estimating true depression prevalence based on
PHQ-9eobtained prevalence for the Kenyan English and Swahili
versions using the psychometric properties obtained in this
study. When adjusting for false positive and false negatives, the
PHQ-9eidentiﬁed prevalence rates for depression and anxiety
can be adjusted to approximate what the true prevalence may be
in the population. For example, if a prevalence of 39% is identiﬁed
for depression among 15e19-year-old adolescents using the
English language version, the estimated true prevalence is likely
closer to 20%. A true prevalence of 20% would correspond with a
detected prevalence rate of 45%. The degree of adjustment differs
based on prevalence because of the contribution of false positive
versus false negatives to the estimates made. The PPV and NPV
for individual adolescents also vary by prevalence rates (also
included in Figure 3). Policy makers can use algorithms or ﬁgures
such as this to make adjusted prevalence estimates when allocating resources and designing programs. This is important
because at common true prevalence rates of 10%e20%, the PHQ-9
overestimates population prevalence by two-fold to three-fold.
Discussion
Lack of culturally adapted and validated tools has been a
barrier to national-level data on adolescent mental health, which
can inform policies and investment in implementing or scaling
up programs. This work contributes to the evidence of availability of suitable and validated tools in LMICs such as Kenya. The
culturally adapted PHQ-9 in Kenyan English and Swahili languages for use among adolescents uses a terminology that is
clearly understood by adolescents, thus allowing for easy
administration and communication with respondents, and has
been developed through a stakeholder-led translation and
adaptation process. The internal consistency of PHQ-9 in this
study was similar to the values found in other studies, which
ranged from 0.824 to 0.869 [37,46]. For the adolescents aged 15e
19 years, the sensitivity at the cut-off value of 10 for English
version and 9 for Swahili version or more was 93.0%, and the
speciﬁcity was between 67.0% and 74.0%. These values, in
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particular, the sensitivity, are higher than those reported in two
meta-analyses using PHQ-9, although those studies reported
ﬁndings of adults aged more than 18 years [47,48]. These cut-offs
among Kenyan adolescents are with the range of meta-analyses
identiﬁed the optimal cut-off points for diagnosing major
depressive episodes, ranging from 8 to 11 [49].
The validation results among adolescents demonstrated
psychometric properties comparable to results for adults and
high-income settings [34]. A cut-off score of > 8 produced psychometric properties comparable to ﬁndings in the literature
across other LMICs like Argentina [50], Thailand [51], Malaysia
[52], and South Africa [53].
Limitations
This analysis is among the ﬁrst to include adolescents as
young as 10 years old in clinical validation approaches using
population-level mental health measures in Kenya. Due to the
small number of adolescents aged 10e14 years who were found
to have depression on screening (N ¼ 5), were not able to report
results for this group. Despite challenges posed by restrictions

related to the COVID-19 pandemic, it was possible to conduct the
work, although during a longer period than initially planned.
The validation only addressed Kenyan English and Swahili,
Kenya’s two ofﬁcial working languages. We did not validate the
tool for other languages spoken in Kenya like other Bantu languages widely spoken, including Kikuyu, Kamba, and Luhya. Also,
the work was conducted around two periurban informal settlements (Nairobi) with diverse ethnicities, although this does not
include rural settings. Therefore, the extrapolation of the tool to
rural settings should be taken with caution. Despite these limitations, this work contributes to an improved measurement of
adolescent mental health in Kenya using a tool only used among
adults and is now culturally adapted and validated for use among
adolescents in the country.
Conclusion
Validation results of the culturally adapted PHQ-9 in Kenya
showed satisfactory performance for detecting depression
among adolescents. Through this effort, we are contributing to
strengthening the evidence and availability of culturally and

Table 2
Validation psychometrics of patient health questionnairee9 (PHQ-9)
Cut-off

Sensitivity

English Overall
6
1.00
7
0.95
8
0.95
‡9
0.95
 10
0.84
 11
0.79
 12
0.68
Swahili Overall
6
1.00
7
1.00
8
0.95
‡9
0.89
 10
0.74
 11
0.63
 12
0.58
 13
0.58
Cut-Off

Sensitivity

15e19 Years English
7
1.00
8
1.00
9
1.00
‡ 10
0.93
 11
0.86
 12
0.86
 13
0.86
 14
0.79
15e19 Years Swahili
7
1.00
8
1.00
‡9
0.93
 10
0.79
 11
0.71
 12
0.64
 13
0.64
 14
0.57

Speciﬁcity

PLR

NPR

Diagnostic
OR

Youden’s J

TP

FN

TN

FP

PPV

NPV

%
Accuracy

0.50
0.59
0.68
0.73
0.77
0.81
0.85

1.99
2.33
3.00
3.53
3.67
4.24
4.65

0.00
0.09
0.08
0.07
0.20
0.26
0.37

26.2
39.0
49.1
17.9
16.4
12.6

0.498
0.540
0.631
0.679
0.613
0.603
0.537

19
18
18
18
16
15
13

0
1
1
1
3
4
6

115
137
158
169
178
188
197

116
94
73
62
53
43
34

0.14
0.16
0.20
0.23
0.23
0.26
0.28

1.00
0.99
0.99
0.99
0.98
0.98
0.97

53.6
62
70.4
74.8
77.6
81.2
84

0.45
0.54
0.63
0.70
0.77
0.81
0.87
0.89

1.82
2.16
2.57
2.95
3.21
3.39
4.31
5.14

0.00
0.00
0.08
0.15
0.34
0.45
0.49
0.47

30.9
19.6
9.4
7.5
8.9
10.8

0.450
0.537
0.579
0.592
0.507
0.445
0.445
0.466

19
19
18
17
14
12
11
11

0
0
1
2
5
7
8
8

104
124
146
161
178
188
200
205

127
107
85
70
53
43
31
26

0.13
0.15
0.17
0.20
0.21
0.22
0.26
0.30

1.00
1.00
0.99
0.99
0.97
0.96
0.96
0.96

49.2
57.2
65.6
71.2
76.8
80
84.4
86.4

Speciﬁcity

PLR

NPR

Diagnostic
OR

Youden’s J

TP

FN

TN

FP

PPV

NPV

%
Accuracy

0.54
0.66
0.71
0.74
0.79
0.84
0.85
0.87

2.16
2.93
3.42
3.57
4.05
5.27
5.55
6.04

0.00
0.00
0.00
0.10
0.18
0.17
0.17
0.25

37.0
22.4
30.9
32.8
24.5

0.537
0.659
0.707
0.668
0.646
0.695
0.703
0.656

14
14
14
13
12
12
12
11

0
0
0
1
2
2
2
3

66
81
87
91
97
103
104
107

57
42
36
32
26
20
19
16

0.20
0.25
0.28
0.29
0.32
0.38
0.39
0.41

1.00
1.00
1.00
0.99
0.98
0.98
0.98
0.97

58.4
69.3
73.7
75.9
79.6
83.9
84.7
86.1

0.47
0.59
0.67
0.74
0.77
0.83
0.86
0.88

1.89
2.41
2.86
3.02
3.14
3.77
4.65
4.69

0.00
0.00
0.11
0.29
0.37
0.43
0.41
0.49

27.0
10.4
8.5
8.7
11.2
9.6

0.472
0.585
0.603
0.526
0.487
0.472
0.505
0.449

14
14
13
11
10
9
9
8

0
0
1
3
4
5
5
6

58
72
83
91
95
102
106
108

65
51
40
32
28
21
17
15

0.18
0.22
0.25
0.26
0.26
0.30
0.35
0.35

1.00
1.00
0.99
0.97
0.96
0.95
0.95
0.95

52.6
62.8
70.1
74.5
76.6
81.0
83.9
84.7

Validation psychometrics of Patient Health Questionnaire (PHQ-9, Kenyan English, and Swahili versions) from comparison with the Kiddie Schedule of Affective Disorders and Schizophrenia (K-SADS DSM-5 depression). Appropriate cut-off pont for screening of depression are indicated in bold.
PHQ-9, Patient Health Questionnaire; PPV, Positive predictive value; NPV, Negative predictive value; PLR, Positive likelihood ratio; NLR, Negative likelihood ratio; OR,
Odds ratio; TP, True positive; TN, True negative; FP, False positive; FN, False negative.
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Table 3
Discriminant ability of PHQ-9 items for adolescents with and without depressive disorder diagnoses on the kiddie schedule of affective disorders and schizophrenia
PHQ-9 items
English

Item 1: little interest/pleasure
item 2: feeling down/depressed
Item 3: sleep
Item 4: tired
Item 5: appetite/overeating
Item 6: bad about yourself
Item 7: trouble concentrating
Item 8: moving/speaking
Item 9: thoughts dead
PHQ-9 Total Scores

Overall (N ¼ 250)

15e19 Years (n ¼ 137)

Not depressed

Depressed

Mean  SD

Mean  SD

0.90
0.93
0.70
0.84
0.69
0.77
0.77
0.58
0.39
6.55












0.89
0.91
0.89
0.95
0.98
0.98
0.95
0.83
0.80
5.05

1.58
1.84
1.53
2.00
2.00
2.42
1.42
1.47
1.58
15.84












1.07
1.07
1.22
0.94
1.20
0.96
1.17
1.02
1.17
6.34

p value

<
<
<
<
<

Not depressed

Depressed

Mean  SD

Mean  SD

.123
.000
.083
.001
.001
.001
.049
.001
.003
.001

0.94
0.93
0.76
0.86
0.80
0.97
0.78
0.62
0.37
7.03












0.91
0.93
0.94
0.95
1.08
1.06
0.98
0.89
0.77
5.14

1.64
2.00
1.71
2.00
2.14
2.64
1.71
1.57
1.79
17.21












1.15
1.18
1.20
0.96
1.17
0.74
1.20
1.02
1.12
5.92

p value

<
<
<

<
<

.080
.001
.005
.001
.001
.001
.011
.002
.001
.001

Swahili

Overall (N ¼ 250)

Item 1: kupoteza hamu/
furaha
item 2: Kukosa furaha au
kuboeka/mawazo mengi
Item 3: usingizi
Item 4: kuchoka
Item 5: hamu ya kula/kula
sana
Item 6: vibaya kujihusu
Item 7: shida ya kuzingatia au
kuwa makini
Item 8: kutembea/kuongea
Item 9: mawazo kufa
PHQ-9 Total Scores

0.80  0.80

1.79  0.98

.003

0.87  0.82

15e19 Years (n ¼ 137)
1.93  1.00

< .001

0.94  0.82

2.21  0.98

< .001

1.12  0.83

2.36  0.93

< .001

0.73  0.98
0.77  0.83
0.79  0.96

1.58  1.12
1.63  1.01
1.68  1.16

.004
.015
.034

0.76  1.00
0.89  0.90
0.87  0.97

1.57  1.09
1.64  1.08
1.86  1.17

.044
.042
.005

0.90  1.01
0.77  0.89

1.95  0.97
1.32  1.00

< .001
.102

1.08  1.08
0.77  0.84

2.00  1.04
1.50  1.09

.026
.031

0.59  0.84
0.37  0.70
6.66  5.15

1.74  1.15
1.53  1.22
15.42  6.87

.004
.006
< .001

0.65  0.90
0.40  0.72
7.41  5.26

1.93  1.14
1.71  1.20
16.50  6.96

< .001
< .001
< .001

clinically valid measurement tools to determine the prevalence
of depression at the population level, increasing the feasibility of
data collection by using tools that trained interviewers can
administer in the context of population-based data collection. In
addition, the range of cut-off scores provided with this analysis
can inform practitioners, including clinicians, policymakers, and
researchers, to identify the best ﬁt for the intended use in Kenyan
settings.
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